FDA approves azilsartan/chlorthalidone for hypertension

FDA approved an NDA from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) for Edarbyclor azilsartan/chlorthalidone to treat hypertension. The product is a fixed-dose combination of azilsartan, an angiotens...